Article ; Online: Addendum to British Society for Haematology Guideline for the management of mantle cell lymphoma, 2018 (Br. J. Haematol. 2018; 182: 46-62): Risk assessment of potential CAR T candidates receiving a covalent Bruton tyrosine kinase inhibitor for relapsed/refractory disease.
British journal of haematology
2022 Volume 199, Issue 1, Page(s) 40–44
MeSH term(s) | Adult ; Hematology ; Humans ; Lymphoma, Mantle-Cell/drug therapy ; Neoplasm Recurrence, Local ; Protein Kinase Inhibitors/adverse effects ; Receptors, Chimeric Antigen ; Risk Assessment |
---|---|
Chemical Substances | Protein Kinase Inhibitors ; Receptors, Chimeric Antigen |
Language | English |
Publishing date | 2022-07-27 |
Publishing country | England |
Document type | Journal Article |
ZDB-ID | 80077-6 |
ISSN | 1365-2141 ; 0007-1048 |
ISSN (online) | 1365-2141 |
ISSN | 0007-1048 |
DOI | 10.1111/bjh.18378 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Uh III Zs.182: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.